Want to see FR:EMEIS full AI Analyst Report?
EMEIS Stock Chart & Stats
€13.77
-€0.05(-0.36%)
At close: 4:00 PM EDT
€13.77
-€0.05(-0.36%)
Day’s Range― - ―
52-Week Range€10.72 - €16.19
Previous CloseN/A
Volume223.98K
Average Volume (3M)485.78K
Market Cap
€2.35B
Enterprise Value€10.44K
Total Cash (Recent Filing)€337.00M
Total Debt (Recent Filing)€8.02B
Price to Earnings (P/E)―
Beta1.13
Next Earnings
May 07, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.64
Shares Outstanding161,440,050
10 Day Avg. Volume432,757
30 Day Avg. Volume485,783
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.64
Price to Sales (P/S)0.39
P/FCF Ratio4.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€16.00Price Target Upside16.19% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-0.87
Revenue Forecast (FY)€6.07B
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationThe business produces positive operating and free cash flow, with a marked improvement in 2025. Durable cash generation supports ongoing liquidity, funds maintenance capex, and provides a real engine for gradual deleveraging and creditor confidence even while accounting profits remain volatile.
Revenue And Occupancy MomentumSustained organic growth and rising occupancy are structural drivers for recurring revenues in care services. Higher utilization plus selective pricing underpin revenue durability, improve cash flow conversion, and create a stronger base for margin recovery across the estate over the medium term.
Operational 'Boost' Efficiency ProgramA clear, repeatable OpEx program (consolidated pharmacies, laundry renegotiation, standardization) can sustainably lift margins. If executed broadly, 2% p.a. savings compound over time, supporting the company's mid‑term EBITDA CAGR targets and easing pressure on cash flow and leverage.
Bears Say
Elevated Absolute LeverageHigh absolute debt materially reduces financial flexibility and increases refinancing and covenant risk. Bringing leverage down to covenant levels requires sustained strong cash conversion, disposals or capital actions; any setback in operations or proceeds would prolong balance‑sheet strain.
Persistent Accounting LossesAlthough trending better, continued net losses constrain equity rebuild and restrict internal funding for growth or distributions. Relying on operational improvements and disposals to close the profitability gap increases execution risk and leaves earnings susceptible to inflation and capex swings.
Limited Disposal Levers And Rising Maintenance CapexWith the bulk of planned disposals already executed, management has fewer easy one-off sources of liquidity. Combined with increased maintenance capex needs, this limits near-term free‑cash flexibility and slows the pace at which the group can credibly reduce leverage absent stronger operating cash flow.
Orpea SA News
EMEIS FAQ
What was Orpea SA’s price range in the past 12 months?
Orpea SA lowest stock price was €10.72 and its highest was €16.19 in the past 12 months.
What is Orpea SA’s market cap?
Orpea SA’s market cap is €2.35B.
When is Orpea SA’s upcoming earnings report date?
Orpea SA’s upcoming earnings report date is May 07, 2027 which is in 275 days.
How were Orpea SA’s earnings last quarter?
Orpea SA released its earnings results on Jul 29, 2026. The company reported -€0.25 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Orpea SA overvalued?
According to Wall Street analysts Orpea SA’s price is currently Undervalued.
Does Orpea SA pay dividends?
Orpea SA pays a Notavailable dividend of €57.478 which represents an annual dividend yield of N/A. See more information on Orpea SA dividends here
What is Orpea SA’s EPS estimate?
Orpea SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orpea SA have?
Orpea SA has 161,440,050 shares outstanding.
What happened to Orpea SA’s price movement after its last earnings report?
Orpea SA reported an EPS of -€0.25 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.353%.
Which hedge fund is a major shareholder of Orpea SA?
Currently, no hedge funds are holding shares in FR:EMEIS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Orpea SA
Emeis Société anonyme operates as a prominent provider of diverse healthcare services, encompassing the management of nursing homes, assisted-living facilities, specialized post-acute and rehabilitation hospitals, and psychiatric treatment centers. Within its elderly care residences, the company delivers tailored support alongside comprehensive logistical and residential amenities, including comfortable accommodation, meal services, laundry, and room maintenance. These facilities also enrich residents' lives with a variety of daily events, recreational activities, and therapeutic workshops. Emeis's post-acute and rehabilitation hospitals are equipped to treat a wide array of medical conditions, such as geriatric issues, musculoskeletal and neurological disorders, cardiovascular and hematological ailments, oncology recovery, and care for individuals in persistent vegetative or minimally conscious states. The psychiatric hospitals address an extensive spectrum of mental health concerns, ranging from mood, anxiety, and obsessive-compulsive disorders to addictions, eating disorders, sleep disturbances, personality disorders, age-related psychiatric conditions, psychosis, and stress-induced conditions like burnout, chronic fatigue syndrome, fibromyalgia, psychosomatic issues, and post-traumatic stress disorder. Furthermore, they offer specialized psychiatric care for geriatrics, children, young adults, and parent-child dynamics, serving both public and private patients. Complementing its institutional offerings, Emeis also provides comprehensive home care solutions. These include practical domestic assistance such as cleaning, meal preparation, ironing, gardening, and running errands; daily living support encompassing day or night supervision and aid with hygiene and meals; and mobility assistance. Founded in 1989 and headquartered in Puteaux, France, the company maintains an expansive international presence, with operations spanning numerous countries across Europe, Latin America, and Asia, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China.
EMEIS Stock 12 Month Forecast
Average Price Target
€16.00
▲(16.19% Upside)
Technical Analysis
Eurofins Scientific
―
Clariane
―
LNA Sante SA
―
Equasens
―
Ramsay Generale de Sante
―


